This article is from the source 'guardian' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.theguardian.com/australia-news/2019/jun/24/two-workers-exposed-to-unsafe-radiation-dose-at-lucas-heights-nuclear-facility

The article has changed 2 times. There is an RSS feed of changes available.

Version 0 Version 1
Two workers exposed to unsafe radiation dose at Lucas Heights nuclear facility Two workers exposed to unsafe radiation dose at Lucas Heights nuclear facility
(32 minutes later)
Production has ceased and an urgent investigation has been launched after two employees at a newly-opened Australian nuclear medicine facility at Lucas Heights were exposed to an unsafe dose of radiation late last week. Production has ceased and an urgent investigation has been launched after two employees at a newly opened Australian nuclear medicine facility at Lucas Heights were exposed to an unsafe dose of radiation late last week.
Just two weeks after it was granted a license to enter into full domestic production, the Australian Nuclear Science and Technology Organisation (Antso) has confirmed production at its new $168m nuclear medicine facility has been halted after “a safety incident” on Friday morning. Just two weeks after it was granted a licence to enter into full domestic production, the Australian Nuclear Science and Technology Organisation (Ansto) has confirmed production at its new $168m nuclear medicine facility has been halted after “a safety incident” on Friday morning.
Antso said three of its workers were “attended to by radiation protection personnel” after the incident, in which contamination was detected on the outside of a container holding 42 millilitres of the radioisotope molybdenum-99 (Mo-99). Ansto said three of its workers were “attended to by radiation protection personnel” after the incident, in which contamination was detected on the outside of a container holding 42 millilitres of the radioisotope molybdenum-99 (Mo-99).
Two of those workers received a radiation dose above the legal limit roughly equivalent to a conventional cancer radiation therapy treatment, an Antso spokesman said. Two of those workers received a radiation dose above the legal limit roughly equivalent to a conventional cancer radiation therapy treatment, an Ansto spokesman said.
Fault at Lucas Heights nuclear reactor halts production of medical isotopeFault at Lucas Heights nuclear reactor halts production of medical isotope
“Antso has launched an urgent investigation after three employees were involved in a safety incident at our brand-new nuclear medicine facility,” the spokesman said. “Ansto has launched an urgent investigation after three employees were involved in a safety incident at our brand new nuclear medicine facility,” the spokesman said. “An investigation commenced on Friday, and both the nuclear regulator, Arpansa, and Comcare have been informed. An estimate of the radiation dose will be confirmed in coming weeks.
“An investigation commenced on Friday, and both the nuclear regulator, Arpansa, and Comcare have been informed. An estimate of the radiation dose will be confirmed in coming weeks. “Early calculations indicate that the radiation dose received by two of the workers involved in medicine processing was equivalent to that of a conventional radiation therapy treatment.
“Early calculations indicate that the radiation dose received by two of the workers involved in medicine processing, was equivalent to that of a conventional radiation therapy treatment. “An occupational physician will continue to provide ongoing observation. All three workers involved are receiving ongoing support from Ansto.”
“An occupational physician will continue to provide ongoing observation. All three workers involved are receiving ongoing support from Antso.”
Located at the Lucas Heights nuclear facility in Sydney’s south, the $168m nuclear medicine facility was announced by the federal government in 2012 with the goal of tripling Australian production of Mo-99, the parent isotope of Technetium-99m.Located at the Lucas Heights nuclear facility in Sydney’s south, the $168m nuclear medicine facility was announced by the federal government in 2012 with the goal of tripling Australian production of Mo-99, the parent isotope of Technetium-99m.
The isotope is used in hospitals and nuclear medicine centres to diagnose a variety of heart, lung, organ and muscular-skeletal conditions. The isotope is used in hospitals and nuclear medicine centres to diagnose a variety of heart, lung, organ and musculoskeletal conditions.
The facility only received approval to enter into full domestic production on 13 June this year.The facility only received approval to enter into full domestic production on 13 June this year.
At the time, Antso chief executive Dr Adi Paterson called it “the most advanced and safest manufacturing facility for nuclear medicine on the planet today”. At the time, the Ansto chief executive, Dr Adi Paterson, called it “the most advanced and safest manufacturing facility for nuclear medicine on the planet today”.
Australians' support for nuclear plants rising – but most don't want to live near oneAustralians' support for nuclear plants rising – but most don't want to live near one
“This is a highly sophisticated manufacturing facility that will see the Shire contributing strongly to health outcomes for patients across Australia, and the wait has been worth it,” Paterson said. “This is a highly sophisticated manufacturing facility that will see the shire contributing strongly to health outcomes for patients across Australia, and the wait has been worth it,” Paterson said.
However in a statement on Monday, Antso said it would now conduct an investigation into the “design, manufacture, operations, protocols and procedures as well as training” at the facility. However, in a statement on Monday, Ansto said it would now conduct an investigation into the “design, manufacture, operations, protocols and procedures as well as training” at the facility.
“Vital supplies of molybdenum-99 nuclear medicine are currently being provided through alternative facilities at Antso, while the investigation is underway,” the spokesman said. “Vital supplies of molybdenum-99 nuclear medicine are currently being provided through alternative facilities at Ansto, while the investigation is under way,” the spokesman said.
It is the second contamination scare at the Lucas Heights facility in only a few months.It is the second contamination scare at the Lucas Heights facility in only a few months.
In March three staff at the Lucas Heights nuclear facility were taken to hospital after they were exposed to sodium hydroxide when a cap came off a pipe in the nuclear medicine manufacturing building.In March three staff at the Lucas Heights nuclear facility were taken to hospital after they were exposed to sodium hydroxide when a cap came off a pipe in the nuclear medicine manufacturing building.
New South WalesNew South Wales
Nuclear wasteNuclear waste
SydneySydney
HealthHealth
newsnews
Share on FacebookShare on Facebook
Share on TwitterShare on Twitter
Share via EmailShare via Email
Share on LinkedInShare on LinkedIn
Share on PinterestShare on Pinterest
Share on WhatsAppShare on WhatsApp
Share on MessengerShare on Messenger
Reuse this contentReuse this content